Alex Gordon

Alex Gordon is an experienced professional with a diverse work history. Since May 2019, they have been the CEO and Co-founder of Revolve Surgical, where they are involved in pioneering a new generation of low-cost robotic surgery. This involves developing an advanced and accessible platform that aims to reduce the size, cost, and training requirements of current surgical robots.

In addition to their role at Revolve Surgical, Alex has also been a CDL Alumni in the 2019-2020 Health Stream at Creative Destruction Lab since September 2019. At this organization, they have likely been involved in innovative projects related to the health industry.

From May 2017 to June 2020, Alex worked as a Biomedical Engineer at The Hospital for Sick Children. This role likely involved utilizing their engineering expertise to support the development and maintenance of biomedical equipment used in medical procedures.

Before joining The Hospital for Sick Children, Alex gained experience as an Engineering Design TA at the University of Toronto from September 2017 to May 2019. This role involved assisting in the instruction of engineering design courses.

Prior to their time at the University of Toronto, Alex served as a Structures and Mechanisms Engineer at Multimatic Inc. from August 2014 to May 2016. In this role, they likely contributed to the design and development of structures and mechanisms used in various industries.

Overall, Alex Gordon has a diverse background in engineering and healthcare, with experience ranging from robotic surgery to biomedical equipment and engineering education.

Alex Gordon's education history begins in 2009 when they enrolled at the University of Toronto to pursue a Bachelor of Applied Science (BASc) degree. Their field of study during this time included solid mechanics, mechatronics, robotics, and engineering business. Alex completed their undergraduate program in 2013.

After obtaining their bachelor's degree, Alex Gordon continued their education and enrolled in a doctoral program at the University of Toronto. From 2016 to 2021, they pursued a Doctor of Philosophy (PhD) degree in the field of biomedical/medical engineering.